Treatment for multiple sclerosis has changed considerably in the last few years. Four multicentre, double-blind, placebo-controlled studies have resulted in licenses being issued for a number of preparations. The present summary discusses the study results and clinical aspects of beta interferon therapy.
|Translated title of the contribution||Immunomodulatory treatment of multiple sclerosis with betainterferon|
|Number of pages||3|
|Journal||Munchener Medizinische Wochenschrift|
|Publication status||Published - márc. 12 1999|
ASJC Scopus subject areas